Register      Login
Reproduction, Fertility and Development Reproduction, Fertility and Development Society
Vertebrate reproductive science and technology

Articles citing this paper

Pregnancy-associated plasma protein A (PAPP-A): measurement by highly sensitive and specific enzyme immunoassay, importance of first-trimester serum determinations, and stability studies

NA Bersinger, P Marguerat, G Pescia and H Schneider
7(6) pp.1419 - 1423


22 articles found in Crossref database.

Second-trimester serum levels of placenta growth factor (PLGF) and inhibin A are increased in smokers. Implications for pre-eclampsia risk assessment
Bersinger N.A., Ødegård R.A.
Immuno-analyse & Biologie Spécialisée. 2007 22(1). p.19
Maternal serum levels of placental proteins after in vitro fertilisation and their implications for prenatal screening
Bersinger N. A., Wunder D., Vanderlick F., Chanson A., Pescia G., Janecek P., Boillat E., Birkhäuser M. H.
Prenatal Diagnosis. 2004 24(6). p.471
(2007)
Palomaki Glenn E., Lambert‐Messerlian Geralyn M., Canick Jacob A.
Serum markers for pre-eclampsia: An update on the analytes to be determined in the first, second, and third trimester
Bersinger N.A., Baumann M.U.
Immuno-analyse & Biologie Spécialisée. 2009 24(2). p.58
First trimester serum concentrations of placental proteins in singleton and multiple IVF pregnancies: implications for Down syndrome screening
Bersinger N.A., Vanderlick F., Birkhäuser M.H., Janecek P., Wunder D.
Immuno-analyse & Biologie Spécialisée. 2005 20(1). p.21
A prospective clinical trial to compare the performance of dried blood spots prenatal screening for Down’s syndrome with conventional non-invasive testing technology
Hu Huiying, Jiang Yulin, Zhang Minghui, Liu Shanying, Hao Na, Zhou Jing, Liu Juntao, Zhang Xiaojin, Ma Liangkun
Experimental Biology and Medicine. 2017 242(5). p.547
Tietz Textbook of Clinical Chemistry and Molecular Diagnostics (2012)
Ashwood Edward R., Grenache David G., Lambert-Messerlian Geralyn
Maternal serum pregnancy-associated plasma protein A (PAPP-A) but not pregnancy-specific β1-glycoprotein (SP1) is a useful second-trimester marker for fetal trisomy 18
Bersinger N. A., Leporrier N., Herrou M., Leymarie P.
Prenatal Diagnosis. 1999 19(6). p.537
The stability of free‐β human chorionic gonadotrophin and pregnancy‐associated plasma protein‐A in first trimester dried blood spots
Cowans Nicholas J., Stamatopoulou Anastasia, Liitti Paivi, Suonpaa Mikko, Spencer Kevin
Prenatal Diagnosis. 2011 31(3). p.293
Women with Preeclampsia Have Increased Serum Levels of Pregnancy‐Associated Plasma Protein A (PAPP‐A), Inhibin A, Activin A and Soluble E‐selectin
Bersinger Nick A., Smárason Alexander K., Muttukrishna Shanthi, Groome Nigel P., Redman Christopher W.
Hypertension in Pregnancy. 2003 22(1). p.45
Stability of first- and second-trimester serum markers after storage and shipment
Lambert-Messerlian Geralyn M., Eklund Elizabeth E., Malone Fergal D., Palomaki Glenn E., Canick Jacob A., D'Alton Mary E.
Prenatal Diagnosis. 2006 26(1). p.17
Point-of-Care Time-resolved Immunofluorometric Assay for Human Pregnancy-associated Plasma Protein A: Use in First-Trimester Screening for Down Syndrome
Qin Qiu-Ping, Christiansen Michael, Pettersson Kim
Clinical Chemistry. 2002 48(3). p.473
First‐trimester maternal serum PAPP‐A, SP1 and M‐CSF levels in normal and trisomic twin pregnancies
Bersinger N. A., Noble P., Nicolaides K. H.
Prenatal Diagnosis. 2003 23(2). p.157
Early biochemical detection of pre-eclampsia: the role of placental proteins
Bersinger Nick A, Ødegård Rønnaug
Immuno-analyse & Biologie Spécialisée. 2004 19(1). p.47
The proform of eosinophil major basic protein: a new maternal serum marker for Down syndrome
Christiansen Michael, Oxvig Claus, Wagner Jill M., Qin Qiu-Ping, Nguyen Tri H., Overgaard Michael T., Larsen Severin O., Sottrup-Jensen Lars, Gleich Gerald J., Nørgaard-Pedersen Bent
Prenatal Diagnosis. 1999 19(10). p.905
Glycosylation of pregnancy-associated plasma protein A (PAPP-A) and pregnancy-specific β1-glycoprotein (SP1): Relevance for fetal down syndrome screening and for placental function studies
Bersinger NA, Xin Wei Zhi
Immuno-analyse & Biologie Spécialisée. 2000 15(6). p.402
PAPP‐A and free ß‐hCG stability in first trimester serum using PerkinElmer AutoDELFIA® and DELFIA® Xpress systems
Cowans Nicholas J., Stamatopoulou Anastasia, Hellström Johanna, Mäkelä Minna‐Maarit, Spencer Kevin
Prenatal Diagnosis. 2010 30(2). p.127
Aspirin for evidence-based preeclampsia prevention trial: effects of aspirin on maternal serum pregnancy-associated plasma protein A and placental growth factor trajectories in pregnancy
Rolnik Daniel L., Syngelaki Argyro, O’Gorman Neil, Wright David, Nicolaides Kypros H., Poon Liona C.
American Journal of Obstetrics and Gynecology. 2024 231(3). p.342.e1
La PAPP-A
Gaillard O
Immuno-analyse & Biologie Spécialisée. 2003 18(6). p.338
Second‐ and third‐trimester serum levels of placental proteins in preeclampsia and small‐for‐gestational age pregnancies
Bersinger Nick A., Ødegård Rønnaug A.
Acta Obstetricia et Gynecologica Scandinavica. 2004 83(1). p.37
Down's syndrome screening: a controversial test, with more controversy to come!
Reynolds T M
Journal of Clinical Pathology. 2000 53(12). p.893
Examination of the pregnancy-associated plasma protein-A assay on the Beckman Coulter Access® platform: suitability for use in first trimester Down's syndrome screening
Lambert-Messerlian Geralyn, Palomaki Glenn E, Canick Jacob A
Journal of Medical Screening. 2010 17(3). p.109

Committee on Publication Ethics


Abstract Export Citation Get Permission